154 related articles for article (PubMed ID: 9434456)
1. [Clinical results of troglitazone (CS-045)].
Iwamoto Y
Nihon Rinsho; 1997 Nov; 55 Suppl():131-6. PubMed ID: 9434456
[No Abstract] [Full Text] [Related]
2. Troglitazone for non-insulin-dependent diabetes mellitus.
Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446
[No Abstract] [Full Text] [Related]
3. Troglitazone in type II diabetes mellitus.
Sparano N; Seaton TL
Pharmacotherapy; 1998; 18(3):539-48. PubMed ID: 9620105
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone.
Spencer CM; Markham A
Drugs; 1997 Jul; 54(1):89-101; discussion 102. PubMed ID: 9211083
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus.
Parker JC
Adv Drug Deliv Rev; 2002 Nov; 54(9):1173-97. PubMed ID: 12393300
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone-induced pulmonary edema.
Inoue K; Sano H
Arch Intern Med; 2000 Mar; 160(6):871-2. PubMed ID: 10737290
[No Abstract] [Full Text] [Related]
7. Advisory panel hears contradictory evidence, backs keeping troglitazone on market.
Miller JL
Am J Health Syst Pharm; 1999 May; 56(9):840, 842. PubMed ID: 10344603
[No Abstract] [Full Text] [Related]
8. [Meta-analysis shows: insulin sensitizer is safe for the liver].
MMW Fortschr Med; 2002 Oct; 144(40):47. PubMed ID: 12440297
[No Abstract] [Full Text] [Related]
9. A novel antidiabetic drug, troglitazone--reason for hope and concern.
Imura H
N Engl J Med; 1998 Mar; 338(13):908-9. PubMed ID: 9516229
[No Abstract] [Full Text] [Related]
10. The rise and fall of troglitazone.
Bailey CJ
Diabet Med; 2000 Jun; 17(6):414-5. PubMed ID: 10975209
[No Abstract] [Full Text] [Related]
11. Warner-Lambert voluntarily withdraws Rezulin.
Diabetes Technol Ther; 2000; 2(2):290. PubMed ID: 11469273
[No Abstract] [Full Text] [Related]
12. How should patients taking the discontinued diabetes drug troglitazone be managed?
Reddy SS
Cleve Clin J Med; 2000 Jun; 67(6):401-2, 455. PubMed ID: 10860221
[No Abstract] [Full Text] [Related]
13. Hepatic injury due to troglitazone.
Malik AH; Prasad P; Saboorian MH; Thiele DL; Malet PF
Dig Dis Sci; 2000 Jan; 45(1):210-4. PubMed ID: 10695637
[No Abstract] [Full Text] [Related]
14. Effects of troglitazone on insulin sensitivity.
Henry RR
Diabet Med; 1996 Sep; 13(9 Suppl 6):S148-50. PubMed ID: 8894499
[TBL] [Abstract][Full Text] [Related]
15. Update in endocrinology.
Whitcomb RW
Ann Intern Med; 1998 May; 128(10):871. PubMed ID: 9599203
[No Abstract] [Full Text] [Related]
16. [Clinical efficacy of Pioglitazone (AD-4833)].
Kaneko T; Baba S
Nihon Rinsho; 1997 Nov; 55 Suppl():142-6. PubMed ID: 9434458
[No Abstract] [Full Text] [Related]
17. FDA reviews troglitazone.
Donnelly R
Diabetes Obes Metab; 1999 Mar; 1(2):65-6. PubMed ID: 11220513
[No Abstract] [Full Text] [Related]
18. Deterioration of rheumatoid arthritis with troglitazone: a rare and unexpected adverse effect.
Sakurai A; Hashizume K
Arch Intern Med; 2000 Jan; 160(1):118-9. PubMed ID: 10632316
[No Abstract] [Full Text] [Related]
19. Pulmonary edema associated with troglitazone therapy.
Hirsch IB; Kelly J; Cooper S
Arch Intern Med; 1999 Aug 9-23; 159(15):1811. PubMed ID: 10448787
[No Abstract] [Full Text] [Related]
20. Actos (pioglitazone HCL) provides a safe, effective alternative for patients formerly taking Rezulin.
Diabetes Technol Ther; 2000; 2(2):290-1. PubMed ID: 11469274
[No Abstract] [Full Text] [Related]
[Next] [New Search]